HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Sadahiko Arai Go Watanabe Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tabata, S. Articles by Watanabe, G. Search for Related Content PubMed PubMed Citation Articles by Tabata, S. Articles by Watanabe, G. Related Collections Extracorporeal circulation

Eur J Cardiothorac Surg 2004;26:289-293
© 2004 Elsevier Science NL

Efficacy of FK633, an ultra-short acting glycoprotein IIb/IIIa antagonist on platelet preservation during and after cardiopulmonary bypass

Department of General and Cardiothoracic Surgery, Kanazawa University School of Medicine, Takaramachi 13-1, Kanazawa 920-8641, Japan

Received 18 September 2003; received in revised form 11 February 2004; accepted 8 March 2004.

^* Corresponding author. Tel.: +81-76-265-2354; fax: +81-76-222-6833
e-mail: 02117tabata{at}kouseiren-ta.or.jp

Objective: Temporary pharmacologic inhibition of platelet function during and after cardiopulmonary bypass (CPB) (platelet anesthesia) is an attractive strategy for preserving platelets during CPB. We examined the efficacy of FK633, an ultra-short acting glycoprotein IIb/IIIa antagonist. Methods: The study was carried out in six mongrel dogs that received an intravenous bolus of 0.1 mg/kg of FK633 at the time of administration of heparin (group F), and six control dogs (group C). All animals underwent 60 min of normothermic CPB followed by a 2-h observation period. Blood samples for platelet count, platelet aggregation to adenosine diphosphate and parameters concerning the coagulation system were obtained at eight time points. Hemodynamics, bleeding time, and postoperative blood loss were assessed serially. Scanning electron micrograph of the oxygenator's membrane was investigated. Results: FK633 significantly protected platelet number (group F, 59±10% versus group C, 38±15% of the pre-CPB value; P<0.01), and inhibited platelet aggregation to adenosine diphosphate (group F, 13±12% versus group C, 35±9% of the pre-CPB value; P<0.01) during CPB. Postoperative blood loss did not significantly differ between the two groups, but there was a tendency of less bleeding in group F (group F, 73±23 ml versus group C, 111±44 ml; P=0.09). In group F, scanning electron micrograph of the oxygenator's membrane showed that its surface was free from platelets. There were no significant differences between the groups in hemodynamics. Conclusions: An ultra-short acting glycoprotein IIb/IIIa antagonist, FK633, is effective in preventing both platelet aggregation and thrombocytopenia during CPB, and may be effective for minimizing postoperative bleeding.

Key Words: Cardiopulmonary bypass • Platelet • Glycoprotein IIb/IIIa antagonist • Platelet anesthesia

This article has been cited by other articles:

				Y. Hiramatsu Invited commentary Ann. Thorac. Surg., July 1, 2005; 80(1): 257 - 258. [Full Text] [PDF]